401 related articles for article (PubMed ID: 27443433)
1. Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.
Opitz CF; Hoeper MM; Gibbs JS; Kaemmerer H; Pepke-Zaba J; Coghlan JG; Scelsi L; D'Alto M; Olsson KM; Ulrich S; Scholtz W; Schulz U; Grünig E; Vizza CD; Staehler G; Bruch L; Huscher D; Pittrow D; Rosenkranz S
J Am Coll Cardiol; 2016 Jul; 68(4):368-78. PubMed ID: 27443433
[TBL] [Abstract][Full Text] [Related]
2. Capillary pCO2 helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction.
Olsson KM; Sommer L; Fuge J; Welte T; Hoeper MM
Respir Res; 2015 Mar; 16(1):34. PubMed ID: 25853979
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension.
Kramer T; Dumitrescu D; Gerhardt F; Orlova K; Ten Freyhaus H; Hellmich M; Baldus S; Rosenkranz S
Int J Cardiol; 2019 May; 283():152-158. PubMed ID: 30777406
[TBL] [Abstract][Full Text] [Related]
4. Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension.
Gorter TM; van Veldhuisen DJ; Voors AA; Hummel YM; Lam CSP; Berger RMF; van Melle JP; Hoendermis ES
Eur Heart J Cardiovasc Imaging; 2018 Apr; 19(4):425-432. PubMed ID: 28531295
[TBL] [Abstract][Full Text] [Related]
5. Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.
Vanderpool RR; Saul M; Nouraie M; Gladwin MT; Simon MA
JAMA Cardiol; 2018 Apr; 3(4):298-306. PubMed ID: 29541759
[TBL] [Abstract][Full Text] [Related]
6. Out-of-proportion pulmonary hypertension and heart failure with preserved ejection fraction.
Adir Y; Humbert M; Sitbon O; Wolf R; Lador F; Jaïs X; Simonneau G; Amir O
Respiration; 2013; 85(6):471-7. PubMed ID: 22890046
[TBL] [Abstract][Full Text] [Related]
7. CTA-derived left to right atrial size ratio distinguishes between pulmonary hypertension due to heart failure and idiopathic pulmonary arterial hypertension.
Huis In 't Veld AE; Van Vliet AG; Spruijt OA; Handoko ML; Marcus JT; Vonk Noordegraaf A; Bogaard HJ
Int J Cardiol; 2016 Nov; 223():723-728. PubMed ID: 27573596
[TBL] [Abstract][Full Text] [Related]
8. Combined post- and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction.
Dixon DD; Trivedi A; Shah SJ
Heart Fail Rev; 2016 May; 21(3):285-97. PubMed ID: 26714826
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction.
Farrero M; Blanco I; Batlle M; Santiago E; Cardona M; Vidal B; Castel MA; Sitges M; Barbera JA; Perez-Villa F
Circ Heart Fail; 2014 Sep; 7(5):791-8. PubMed ID: 25047042
[TBL] [Abstract][Full Text] [Related]
10. A Clinical and Echocardiographic Score to Identify Pulmonary Hypertension Due to HFpEF.
Berthelot E; Montani D; Algalarrondo V; Dreyfuss C; Rifai R; Benmalek A; Jais X; Bouchachi A; Savale L; Simonneau G; Chemla D; Humbert M; Sitbon O; Assayag P
J Card Fail; 2017 Jan; 23(1):29-35. PubMed ID: 27742455
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Measurement of Lung Diffusing Capacity and Pulmonary Hemodynamics Reveals Exertional Alveolar-Capillary Dysfunction in Heart Failure With Preserved Ejection Fraction.
Fermoyle CC; Stewart GM; Borlaug BA; Johnson BD
J Am Heart Assoc; 2021 Aug; 10(16):e019950. PubMed ID: 34369164
[TBL] [Abstract][Full Text] [Related]
12. The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.
Obokata M; Kane GC; Reddy YNV; Melenovsky V; Olson TP; Jarolim P; Borlaug BA
Eur Heart J; 2019 Dec; 40(45):3707-3717. PubMed ID: 31513270
[TBL] [Abstract][Full Text] [Related]
13. Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction.
Obokata M; Nagata Y; Kado Y; Kurabayashi M; Otsuji Y; Takeuchi M
J Card Fail; 2017 Mar; 23(3):216-220. PubMed ID: 27737768
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction.
Thenappan T; Shah SJ; Gomberg-Maitland M; Collander B; Vallakati A; Shroff P; Rich S
Circ Heart Fail; 2011 May; 4(3):257-65. PubMed ID: 21411741
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
Adir Y; Guazzi M; Offer A; Temporelli PL; Cannito A; Ghio S
Am Heart J; 2017 Oct; 192():120-127. PubMed ID: 28938958
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
Ghio S; Crimi G; Temporelli PL; Traversi E; La Rovere MT; Cannito A; Vizza D; Scelsi L; Raineri C; Guazzi M; Oltrona Visconti L
Eur J Heart Fail; 2018 Apr; 20(4):725-734. PubMed ID: 29148140
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study.
Lam CS; Roger VL; Rodeheffer RJ; Borlaug BA; Enders FT; Redfield MM
J Am Coll Cardiol; 2009 Mar; 53(13):1119-26. PubMed ID: 19324256
[TBL] [Abstract][Full Text] [Related]
18. Diffusion Capacity and Mortality in Patients With Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
Hoeper MM; Meyer K; Rademacher J; Fuge J; Welte T; Olsson KM
JACC Heart Fail; 2016 Jun; 4(6):441-9. PubMed ID: 26874383
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Arterial Capacitance Is an Important Predictor of Mortality in Heart Failure With a Preserved Ejection Fraction.
Al-Naamani N; Preston IR; Paulus JK; Hill NS; Roberts KE
JACC Heart Fail; 2015 Jun; 3(6):467-474. PubMed ID: 26046840
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Artery Denervation Significantly Increases 6-Min Walk Distance for Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension Associated With Left Heart Failure: The PADN-5 Study.
Zhang H; Zhang J; Chen M; Xie DJ; Kan J; Yu W; Li XB; Xu T; Gu Y; Dong J; Gu H; Han Y; Chen SL
JACC Cardiovasc Interv; 2019 Feb; 12(3):274-284. PubMed ID: 30732732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
